Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of inhaled AZD8871

Trial Identifier: D6640C00004
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT02971293
Start Date: December 2016
Primary Completion Date: August 2017
Study Completion Date: August 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation
English Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050
United Kingdom Manchester, United Kingdom, M23 9QZ